Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Meeting Report
  • Published:

Malignant Mesothelioma as both a challenge and an opportunity

Oncogene volume 23, pages 9155–9161 (2004)Cite this article

Abstract

The International Mesothelioma Interest Group sponsored its 7th international meeting in Brescia, Italy from June 24–26, 2004. The meeting, entitled ‘How advanced technology and new drugs are changing the perspectives of patients with malignant mesothelioma’, was organized by Luciano Mutti (Vercelli, Italy) and GF Tassi (Brescia, Italy) and was attended by 350 participants. The general tone of the meeting was that real progress is now coming in the understanding of mesothelioma biology, progress that may soon translate into improved treatment options. The investigators and clinicians agreed on the importance of referring patients with mesothelioma to centers with expertise where patients can receive the best available treatments and can be offered entry into clinical trials of new and promising agents.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

  1. ASL 11, Laboratorio di Oncologia Clinica, Vercelli, Italy

    Luciano Mutti

  2. Lung Biology Center, Box 0854 UCSF, San Francisco General Hospital, University of California, San Francisco, 94110, USA

    V Courtney Broaddus

Authors
  1. Luciano Mutti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V Courtney Broaddus
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luciano Mutti.

Appendix A

Appendix A

International Mesothelioma Interest Group (IMIG) Executive Committee: DH Sterman (President, Philadelphia, USA), SE Mutsaers (Secretary, Perth, Australia), P Baas (Treasurer, Amsterdam, The Netherlands); SM Albelda (Philadelphia, USA), VC Broaddus (San Francisco, USA), MC Jaurand (Creteil, France), H Kindler (Chicago, USA), S Knuutila (Helsinki, Finland), D Mattson (Helsinki, Finland), L Mutti (Vercelli, Italy), T Nakano (Nishinomiya, Japan), H Pass (Detroit, USA), BWS Robinson (Perth, Australia).

GIME: Italian Mesothelioma Group: A Ardizzoni (Parma, Italy), G Gaudino (Novara, Italy), G Guerrera (Rome, Italy), M Maio (Aviano, Italy), C Pinto (Bologna, Italy), C Porta (Pavia, Italy), R. Puntoni (Genoa, Italy), S Porru (Brescia, Italy), L Mutti (Vercelli, Italy), GF Tassi (Brescia, Italy), M Tognon (Ferrara, Italy).

Speakers: Albelda SM (Philadelphia, USA), Armato SG (Chicago, USA), Ascoli V (Roma, Italy), Baas P (Amsterdam, The Netherlands), Bertazzi PA (Milan, Italy), Broaddus VC (San Francisco, USA), Bueno R (Boston, USA), Cacciotti P (Novara, Italy), Carbone M (Chicago, USA), Case BW (Montreal, USA), Clayson H (Sheffield, UK), Cristaudo A (Pisa, Italy), Emri S (Ankara, Turkey), Flores R (New York, USA), Gazdar AF (Dallas, USA), Gibbs AR (Penarth, Wales, UK), Gorini G (Florence, Italy), Gregoire M (Nantes, France), Grossi F (Genova, Italy), Hassan R (Bethesda, USA), Hegmans JPJJ (Rotterdam, The Netherlands), Hei TK (New York, USA), Janne PA (Boston, USA), Jaurand MC (Creteil, France), Jongsma J (Amsterdam, The Netherlands), Kagan E (Bethesda, USA), Kane AB (Providence, USA), Klabatsa A (London, UK), Lake RA (Melbourne, Australia), Lequaglie C (Milan, Italy), Lopez-Rios F (New York, USA), Maffessanti M (Trieste, Italy), Maio M (Aviano, Italy), Marino A (Bologna, Italy), McDonald C (London, UK), Mossman BT (Burlington, USA), Musk AW (Crawley, Australia), Mutsaers SE (Perth, Australia), Mutti L (Vercelli, Italy), Neri M (Genoa, Italy), Obasaju C, O’Brien MER (Surrey, UK), Pass HI (Detroit, USA), Porta C (Pavia, Italy), Puntoni R (Genova, Italy), Ramos-Nino ME (Burlington, USA), Richards W (Boston, USA), Robinson BWS (Perth, Australia), Russo P (Genoa, Italy), Sartore-Bianchi A (Pavia, Italy), Sperandi F (Bologna, Italy), Sterman DH (Philadelphia, USA), Stevens CW (Houston, USA), Stewart DJ (Leicester, UK), Sugarbaker DJ (Boston, USA), Sugarbaker PH (Washington DC, USA), Symanowski JT (Indianapolis, USA), Testa JR (Philadelphia, USA), Unfried K (Dusseldorf, Germany), van Meerbeeck JP (Belgium), van Montfort E (Amsterdam, The Netherlands).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mutti, L., Broaddus, V. Malignant Mesothelioma as both a challenge and an opportunity. Oncogene 23, 9155–9161 (2004). https://doi.org/10.1038/sj.onc.1208180

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208180

Keywords

Search

Advanced search

Quick links